New to Care Across? Sign up to read all comments and join the conversation
Latest research available at a glance
Nivolumab prolongs survival with less side effects in head and neck cancer
Nivolumab prolongs overall survival and reduces side effects in patients with relapsed metastatic head and neck cancer.
Innovative alternative to mastectomy in recurrent breast cancer
Treating recurrent breast cancer with a 2nd lumpectomy and partial breast irradiation brings better results compared to conventional breast surgery.